Dr. Grace McComsey, MD

• Infectious Disease Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Saint Joseph's University / Faculty Of Medicine

  Medical School, 1989

• Long-Term Changes in Carotid Intima-Media Thickness among HIV-Infected Children and Young Adults, 2013-08-28

• Neurocognitive Dysfunction in HIV-Infected Youth: Investigating the Relationship with Immune Activation, 2018-04-28

• Vitamin D Deficiency and Altered Bone Mineral Metabolism in HIV-infected Individuals, 2014-07-08

• Associations of Inflammatory Markers with AIDS and non-AIDS Clinical Events after Initiation of Antiretroviral Therapy: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202, 2014-02-01

• Endothelial Activation Markers Are Linked to HIV Status and Are Independent of Antiretroviral Therapy and Lipoatrophy, 2008-12-15

• Oxidized LDL levels are increased in HIV infection and may drive monocyte activation, 2015-06-01

• Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial, 2011-11-17

• Effects of vitamin D supplementation on carotid intima-media thickness in HIV-infected youth VIRULENCE, 2017-10-05

• Changes in plasma RANKL-osteoprotegerin in a Prospective, Randomized Clinical trial of Initial Antiviral Therapy: A5260s, 2018-07-01

• Insulin Resistance and Markers of Inflammation in HIV-infected Ugandan Children in the CHAPAS-3 Trial, 2019-06-03

• Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir: ACTG A5224 s, A5202 substudy, 2012-07-17

• Serum Albumin Is Associated With Higher Inflammation and Carotid Atherosclerosis in Treated Human Immunodeficiency Virus Infection, 2018-11-17

• HIV Vasculopathy: Role of Mononuclear cell-associated Kruppel-like Factors 2 and 4, 2015-08-24

• Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature, 2015-04-23

• Rosuvastatin Decreases Intestinal Fatty Acid Binding Protein (I-FABP), but Does Not Alter Zonulin or Lipopolysaccharide Binding Protein (LBP) Levels, in HIV-Infected Subjects on Antiretroviral Therapy, 2016-07-20

• HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 disease, 2012-10-01

• Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control, 2022-10-21

• Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV, 2023-03-28

• The Effect of Physical Activity on Cardiometabolic Health and Inflammation in Treated HIV Infection, 2015-10-12

• Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-infected Youth, 2017-12-15

• Subjective Clinical Lipoatrophy Assessment Correlates with DEXA-measured limb fat, 2009-10-16

• Effect of statin on arginine metabolites in treated HIV-infection, 2017-09-28

• Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV, 2017-05-02

• Increased Immune Activation and Exhaustion in HIV-Infected Youth, 2016-12-10

• The Relationship between Vitamin D Status and HIV-Related Complications in HIV-infected Children and Young Adults, 2013-04-16

• Cardiometabolic Complications in youth with perinatally acquired HIV in the era of antiretroviral therapy, 2021-10-15

• Rosuvastatin reduces vascular inflammation and T cell and monocyte activation in HIV-infected subjects on antiretroviral therapy, 2015-04-01

• Positron Emission Tomography to Characterize Dorsocervical Fat Pad Hypertrophy in People with Treated HIV Infection, 2020-03-01

• Risk Factors for Vitamin D Deficiency and Relationship with Cardiac Biomarkers, Inflammation, and Immune Restoration in HIV-Infected Youth, 2012-08-16

• Statins to improve cardiovascular outcomes in treated HIV infection, 2015-11-18

• Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy, 2009-10-01

• Rosuvastatin Decreases Intestinal Fatty Acid Binding Protein (I-FABP), but Does Not Alter Zonulin or Lipopolysaccharide Binding Protein (LBP) Levels, in HIV-Infected Subjects on Antiretroviral Therapy, 2016-07-13

• Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir, 2011-10-13

• Vitamin D and Bone Loss in HIV, 2016-04-16